With a spike of 22,252 cases, India's COVID-19 case count crossed seven lakh on Tuesday while 467 deaths were reported in the last 24 hours. According to the Union Health Ministry, the total count of cases reached 7,19,665 on Tuesday and the death toll has gone up to 20,160. Of the total count of cases, 2,59,557 are active cases and 4,39,948 patients have been cured/discharged/migrated. The total count has increased from six to seven lakh in five days. The Health Ministry said that the number of recovered patients reached 4,39,947 today and the number was 1,80,390 more than the active cases. India's recovery rate has gone up to 61.13 per cent. Maharashtra continued to remain the worst-affected state, 5134 new positive cases and 224 deaths were reported on July 07. Tamil Nadu, being second in the tally, reported 3616 fresh COVID-19 cases and 65 deaths today. 2008 new COVID-19 positive cases and 50 deaths were reported in Delhi. The Union Health Ministry said that COVID-19 tests in India crossed 1 crore mark as a result of continuously expanding network of testing labs in the country. Indian Council of Medical Research (ICMR) said that a total of 2,41,430 samples were tested for COVID-19 on July 6 which has taken the total number of samples tested till Monday to 1,02,11,092.
India's COVID-19 case tally crossed 7 lakh mark with 22,252 new cases and 467 deaths in the last 24 hours. Total positive cases stand at 7,19,665 including 2,59,557 active cases, 4,39,948 cured/discharged/migrated 20,160 deaths, according to Ministry of Health. Maharashtra continues to be the most impacted state from the infection with 2,11,987 cases and 9,026 fatalities due to the virus. While, Tamil Nadu stands at second place with a total of 1,14,978 cases and 1,571 fatalities. The national capital's COVID-19 cases have also crossed 1- lakh mark with 3,115 deaths. The total number of samples tested up to July 6 is 1,02,11,092 of which 2,41,430 samples were tested yesterday, as per Indian Council of Medical Research.
India's COVID-19 tally neared the 7 lakh mark with 6,97,413 cases after 24,248 new cases were reported in the last 24 hours, said the Union Ministry of Health and Family Welfare. As per the Health Ministry, there are 2,53,287 active cases in the country while 4,24,432 patients have been cured or discharged. 425 new deaths were reported in the last 24 hours in the country due to COVID19, taking the number of patients succumbing to the deadly virus to 19,693. As per the Health Ministry, Maharashtra continues to be the most impacted state from the infection with 2,06,619 cases and 8,822 fatalities due to the virus. Tamil Nadu in second place has a total of 1,11,151 cases and 1,510 fatalities. The national capital's COVID-19 cases are also nearing the 1- lakh mark with 99,444 coronavirus cases and 3,067 deaths. The total number of samples tested up to July 5 is 99,69,662 of which 1,80,596 samples were tested yesterday, informed the Indian Council of Medical Research on Monday.
Seema Verma oversees the Medicare and Medicaid programs for the Trump administration. Verma is deciding how often patients will be able to use phone and video visits to see the doctor. She has said it's “crystal clear” that telehealth must continue, says Business Insider. Verma has the power to change certain regulations on doctor phone and video visits. She’s thinking through which types of medicine should be offering care virtually.
Health and Family Welfare Minister Dr Harsh Vardhan launched Drug Discovery Hackathon on July 02. Human Resource Development Minister Ramesh Pokhriyal Nishank also joined the launch ceremony. Hackathon was launched via video conferencing. CSIR DG, Dr. Shekhar C Mande said, "CSIR is extremely pleased to participate in this Drug Discovery Hackathon."
While speaking to ANI in the national capital on June 06 amid coronavirus pandemic, the DG of Council of Scientific and Industrial Research (CSIR), Dr Shekhar C Mande spoke on clinical trials. He said, "Clinical trials of phytopharmaceutical ACQH began yesterday (June 05) and we are going to try it against COVID-19. It is historic in modern medicine, especially in India." "We have chance to tap our traditional knowledge system and its limitless possibilities," CSIR DG added.
World Health Organisation (WHO) has resumed trials of hydroxychloroquine (HCQ). Speaking on it, Director General of Council of Scientific an Industrial Research (CSIR), Dr. Shekhar C Mande said, "We are happy that the WHO resumed trials of hydroxychloroquine (HCQ). I firmly believe that the WHO's decision was taken in haste. It was a kind of knee-jerk reaction. They should have analysed the data on their own before temporarily suspending trials."
Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible. "The study was published in Lancet on hydroxychloroquine and chloroquine and its effect on COVID-19. It is an observational study with statical parameters and analysis which is not sufficiently good. In our letter to the Lancet editor, we have written that the study design and statical interferences are not right therefore study does not deserve any attention of the readers. We believe that WHO's decision to temporarily halt the trials is not correct and demanded that the clinical trials of hydroxychloroquine for its use in COVID-19 cases must resume as early as possible," said Mande after WHO halts clinical trials of hydroxychloroquine for COVID-19.
Hundreds of scientists across the world have a burning question for the World Health Organization. According to Gizmodo, they just petitioned the WHO via an open letter with one demand. The demand is that the WHO acknowledge publicly that the novel coronavirus behind COVID-19 can be airborne. That means it can spread through the air (and linger there) via tiny aerosols emitted by the breath of infected people, not just large droplets. The letter puts the WHO in a tight spot.
While addressing a press conference in the national capital on May 28, the Principal Scientific Advisor (PSA) to the Government of India, Prof K Vijay Raghavan spoke on drug discovery amid coronavirus pandemic. He said, "All India Council for Technical Education (AICTE) and Council of Scientific and Industrial Research (CSIR) have embarked on a drug discovery hackathon- this is a high-end hackathon where students are trained with information on how to do computational drug discovery."